Search results
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today
Investor's Business Daily· 2 years agoA gamble Merck made more than 10 years ago could pay off again for the pharmaceutical giant's stock...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
In what could be a 'big shift' for cancer treatment, mRNA vaccine shows promise against melanoma
USA TODAY via Yahoo News· 1 year agoMessenger RNA vaccines aren't just for COVID anymore. The vaccine technology America learned about...
Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test
Investor's Business Daily· 2 months agoModerna stock surged Monday — nearing its first breakout in over a year — after launching a third...
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...
Investor's Business Daily· 11 months agoGerman biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...
The Surprising Way Mirati Therapeutics Is Angling To Rival Amgen — And Could Succeed
Investor's Business Daily· 2 years agoShares of MRTX stock rocketed Tuesday after Mirati Therapeutics unveiled early — but promising —...
Cancer vaccine being trialled by NHS may herald ‘dawn of a new age’ of treatments
The Independent via Yahoo News· 3 months agoA new mRNA cancer vaccine being trialled in the UK could herald the “dawn of a new age” of...
Mirati drug helps some patients whose lung cancer spread to the brain -study
Reuters via Yahoo News· 2 years agoMirati Therapeutics Inc's experimental drug that targets a specific genetic mutation helped about...
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Reuters via Yahoo News· 1 year ago(Reuters) -Early trial data shows that a combination of Mirati Therapeutics experimental drug adagrasib and Merck & Co's immunotherapy Keytruda helped about half of previously untreated metastatic ...